XML 100 R91.htm IDEA: XBRL DOCUMENT v3.24.0.1
Accumulated Other Comprehensive Income (Loss) - Summary of Changes in Accumulated Other Comprehensive Income (Details) - USD ($)
$ in Thousands
1 Months Ended 12 Months Ended
Mar. 31, 2022
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
AOCI Attributable to Parent, Net of Tax [Roll Forward]        
Balance at the beginning of the period   $ 3,606,112 $ 3,710,670 $ 3,715,023
Other comprehensive income (loss) before reclassifications   3,809 25,657 5,300
(Gain) loss reclassified to net income   (13,131) 6,041 12,660
Pension adjustment [1]   259 (183) 452
Share of investee’s other comprehensive income [2]   0 0 5,721
Reclassification of the Company's share of previously deferred derivative gains to net income [3]   0 (6,723) 0
Net current-period other comprehensive income (loss)   (9,063) 24,792 24,133
Balance at the end of the period   3,058,597 3,606,112 3,710,670
Income (Loss) from equity method investments   55,708 14,549 9,852
Share of investee's other comprehensive income, tax expense $ 1,900   1,912 1,627
Disposal Group, Disposed of by Sale, Not Discontinued Operations | 110 North Wacker        
AOCI Attributable to Parent, Net of Tax [Roll Forward]        
AOCI, reclassification of cash flow hedge 6,700      
Income (Loss) from equity method investments $ (8,600)      
AOCI Attributable to Parent        
AOCI Attributable to Parent, Net of Tax [Roll Forward]        
Balance at the beginning of the period   10,335 (14,457) (38,590)
Pension adjustment   259 (183) 452
Share of investee’s other comprehensive income       5,721
Balance at the end of the period   $ 1,272 $ 10,335 $ (14,457)
[1] The deferred tax impact was not meaningful for the years ended December 31, 2023, 2022, and 2021.
[2] Amount is shown net of deferred tax expense of $1.6 million for the year ended December 31, 2021.
[3] In March 2022, the Company completed the sale of its ownership interest in 110 North Wacker and released a net of $6.7 million from Accumulated other comprehensive income (loss), representing the Company’s $8.6 million share of previously deferred gains associated with the Venture’s derivative instruments net of tax expense of $1.9 million. See Note 2 - Investments in Unconsolidated Ventures for additional information.